Skip to main content

Table 2 Comparisons of the XP C, ERCC2 and ERCC5 alleles and genotypes distributions between patients and controls

From: The effect of tobacco, XPC, ERCC2 and ERCC5 genetic variants in bladder cancer development

  N (%)   
Alleles and Genotypes Controls (N = 193) Patients (N = 193) P value OR (95% CI)
XPC (rs2228001)     
   AA 79 (40.9) 74 (38.3) - 1*
   AC 92 (47.7) 76 (39.4) 0.65 -
   CC 22 (11.4) 43 (22.3) 0.04** 2.09 (1.09-3.99)
   A 250 (64.8) 224 (58.0) - 1*
   C 136 (35.2) 162 (42.0) 0.06 -
ERCC2 (rs13181)     
   AA 86 (44.6) 97 (50.3) - 1*
   AC 86 (44.6) 76 (39.4) 0.30 -
   CC 21 (10.9) 20 (10.4) 0.75 -
   A 258 (66.8) 270 (69.9) - 1*
   C 128 (33.2) 116 (30.1) 0.39 -
ERCC5 (rs17655)     
   GG 87 (45.1) 95 (49.2) - 1*
   GC 86 (44.6) 70 (36.3) 0.21 -
   CC 20 (10.4) 28 (14.5) 0.55 -
   G 260 (67.3) 260 (67.3) - 1*
   C 126 (32.7) 126 (32.7) 0.93 -
  1. 95% CI: Confidence Interval, 1*: reference group, **: Corrected p value (Bonferroni's correction)